Mice lacking apolipoprotein A-V (apoA-V) displayed an increase in serum triglyceride (TG) levels; however, the correlation of apoA-V levels with TG levels in humans is controversial, and the exact mechanism by which apoA-V affects TG levels is unclear. The aim of the present study was to clarify the impact of apoA-V on the lipoprotein subclass profile in preadolescent children, which has not been studied. Method: The study subjects were 178 (89 male, 89 female) 4th grade elementary school children (mean SD: 9.5 0.5 years old). ApoA-V levels were determined by an enzyme-linked immunosorbent assay, and the lipid component of each lipoprotein fraction and their particle sizes were measured by HPLC. Results: Levels of apoA-V showed no gender difference in preadolescent children, and were not affected by anthropometric variables. ApoA-V had a negative association with serum TG levels and TG levels in each lipoprotein fraction, and a positive association with HDL-C. In particular, apoA-V appears to contribute to the increase in cholesterol levels in the larger HDL fraction. Conclusions: It was suggested that apoA-V is a potent modulator of HDL and VLDL components in preadolescent children. 
VLDL metabolism 4) . Plasma TG levels are markedly elevated in apoA-V gene-deficient mice and markedly decreased in human apoA-V gene transgenic mice 1, 5) . Various mechanisms have been proposed to explain apoA-V action on plasma TG levels, such as the inhibition of VLDL production and/or secretion 4) , activation of lipoprotein lipase (LPL) 4, 6) and increased hepatic uptake of TG-rich lipoproteins 6) . On the other hand, in humans, the association of apoA-V and plasma TG levels is controversial. Some studies have demonstrated the association between several polymorphisms within the apoA-V locus and plasma TG levels 7, 8) ; however, the association between apoA-V levels and TG levels is not always demonstrated in humans [9] [10] [11] , although apoA-V genetic variants reduced apoA-V levels
Introduction
A novel apolipoprotein, apolipoprotein A-V (apoA-V), was identified in 2001, and has a strong influence on plasma triglyceride (TG) levels 1, 2) , in spite of its very low plasma concentration 3) . ApoA-V is expressed exclusively in the liver and secreted into plasma. The circulating mature form has a predicted molecular mass of 39 kDa, and is associated mainly with high density lipoprotein (HDL) and to a lesser extent with very low density lipoprotein (VLDL) particles 2) ; however, apoA-V mainly appears to affect apoA-V levels and the lipoprotein subclass profile in preadolescent children in the present study in order to avoid the effects of sex hormones on lipid metabolism 13) or other life-style-related determinants.
Subjects and Methods

Subjects
The subjects were 178 preadolescent children (89 males and 89 females), aged 9.5 0.5 years, in the 4th grade of elementary school, who volunteered to participate in this study. All children were free from disease except for hyperlipidemia and obesity.
Data Collection
Standing height and body weight were measured and the body mass index (BMI) (kg/m 2 ) was obtained. Relative body weight (%) was calculated from the standard weight obtained for sex, age and height on the basis of data from the Ministry of Education, Science, Sports and Culture 14) . Obesity was defined as a relative body weight greater than 120%. All blood samples were obtained from the cubital vein in the morning after a 12-hour fast. Serum total cholesterol (TC) and TG levels were determined by standard enzymatic methods. Plasma apoA-V levels were measured by an enzyme-linked immunosorbent assay using a monoclonal antibody to human apoA-V, as described by Ishihara et al. 12) . Serum lipoprotein analyses were performed by HPLC with gel permeation columns (LipoSEARCH; Skylight-Biotec, Inc., Akita, Japan), which measured cholesterol (C) and TG levels in each lipoprotein fraction and lipoprotein particle size distribution simultaneously. Furthermore, by this method, each lipoprotein was classified on the basis of particle size into 11 subgroups (i.e., large, medium and small VLDL, large, medium and small low density lipoprotein (LDL), and very large, large, medium, small, and very small HDL) 15) . Informed consent was obtained from all parents, and the study was approved by the local ethics committees.
Statistical Analyses
All data are expressed as the means SDs. Group differences between groups were assessed using the Mann-Whiney U test. The correlation coefficients between two variables were determined by Spearman rank analysis. A p value 0.05 was considered significant. All statistical analyses were conducted using the statistical package STATVIEW (version 4.5; Abacus Concepts, Berkeley, CA).
Results
Characteristics of the Subjects
The characteristics of the subjects and C and TG levels in each lipoprotein fraction are shown in Table 1 . In the present subjects, 28 children (15.7%; 14 males and 14 females) were obese. According to the criteria of normal serum lipid levels for Japanese children 16) , 13 children (7.3%; 5 males and 8 females) had hypercholesterolemia ( 220 mg/dL), 10 (5.6%; 5 males and 5 females) had hypertriglyceridemia ( 140 mg/dL), and 2 (1.1%; 1 male and 1 female) had low HDL-C levels ( 40 mg/dL). No sex difference was observed in lipid levels in each lipoprotein fraction. Plasma 
Correlation Coefficients between ApoA-V Levels and the Variables
In simple regression analyses ( Table 2) , no significant association was demonstrated between apoA-V levels and anthropometric variables. TG levels negatively correlated with apoA-V levels in both sexes (males; r 0.418, p 0.0001, females; r 0.373, p 0.0001). While C levels had a positive association with apoA-V levels only in females (r 0.375, p 0.0003). In simple regression analyses between apoA-V levels and C levels in each lipoprotein fraction, a negative association with VLDL-C levels (r 0.338, p 0.0011) and a positive association with HDL-C levels (r 0.415, p 0.0001) were shown in 
Relationship between ApoA-V Levels and Lipid Component in VLDL and HDL Subclasses
TG distribution in 3 VLDL subclasses and C distribution in 5 HDL subclasses are shown in Table 3 . No sex difference was demonstrated at each level. In single regression analyses (Table 4) , apoA-V levels had a negative correlation with TG levels in all VLDL subclasses in both sexes (large VLDL; r 0.386, 
Discussion
The present study demonstrated that, in preadolescent children, plasma apoA-V levels were lower than those reported in adults by the same method 12, 17) . In addition, unlike in adults, no sex difference was demonstrated in apoA-V levels. Furthermore, apoA-V levels appeared to modulate the lipid levels and components of VLDL and HDL fractions independently of obesity.
In adults, apoA-V genetic variants were associated with elevated TG levels 1, 7, 8, 12, [18] [19] [20] and HDL-C levels, contributing to the development of metabolic syndrome 21, 22) . Furthermore, apoA-V genetic variants are associated with atherosclerosis due to the modification of obesity 8) . In children, the promoter region polymorphism in the apoA-V gene also affects TG and HDLC levels 23) ; however, these associations are controversial, because, the effect of apoA-V gene variants on the serum lipid profile may depend on ethnicity 21) . In addition, apoA-V levels, as well as apoA-V genetic variants, may be a determinant of serum lipid profile; however, the impact of apoA-V levels depends on the study subjects. In Japanese healthy adults, apoA-V levels correlated negatively with TG in females but not in males, while a positive correlation with HDL-C was demonstrated in both sexes. In patients with end-stage renal disease, apoA-V levels were reduced, and did not correlate with TG levels but HDL-C levels 17) . In diabetic patients, apoA-V levels had no influence on TG levels in the postprandial state 10) ; the mechanism has not been elucidated. In the present study of preadolescent children, apoA-V levels were revealed to have potent effects on decreasing the TG level in serum and in each lipoprotein fraction and increasing HDL-C. The most striking result in the present study is to clearly show that TG levels of the subject seemed to be precisely determined corresponding to apoA-V levels, namely the relation shows that TG levels strongly depend on apoA-V levels, which circulates without hypertriglyceridemia.
Recent studies have identified apoA-V and apolipoprotein C-(apoC-) as key regulators of plasma TG metabolism 18) . ApoA-V and apo C-are exchangeable constituents of VLDL and HDL with opposing effects on plasma TG metabolism 18) . In animals, Shen et al. delivered apoA-V vector-treated apoC-transgenic mice 24) , which showed decreased TG and increased HDL-C. Fruchart-Najib et al. also showed that transgenic apoA-V expression prevented the development of hypertriglyceridemia in apoC-transgenic mice 25) . These results suggested that apoA-V counterbalances the effect of apoC-on VLDL-TG catabolism, contributing to the amelioration of hypertriglyceridemia in apoC-transgenic mice. Schaap et al. 4) showed that adenovirus-mediated apoA-V production inhibits hepatic VLDL-TG production in addition to its stimulatory effect on VLDL-TG hydrolysis. Merkel and Heeren 26) postulated that apoA-V augments plasma TG hydrolysis by fostering the interaction of TG-rich lipoproteins with endothelium-bound LPL. In the absence of proteoglycans, apoA-V derived from TG-rich lipoproteins and apoA-V transgenic 27) . Another new finding of the present study was the relationship between apoA-V levels and the lipid component in lipoprotein subclasses, indicating that apoA-V levels correlated negatively to TG levels in all VLDL subclasses. In addition, apoA-V had a positive profound association with C levels in very large, large and medium HDL; therefore, it is speculated that apoA-V plays a role in C metabolism in larger HDL particles. Our results are compatible with the report by Shen et al. that, in the apoA-V vector-treated apoC-transgenic mice, increased apoA-V production facilitates increased apolipoprotein A-I content in HDL and -HDL formation 24) . HDL enlargement demonstrated in transgenic mice overexpressing lecithin-cholesteryl acyltransferase (LCAT) 28) , patients with cholesteryl ester transfer protein deficiency 29) , and scavenger receptor class B type mutant mice 30) . According to the characteristic subclass profile in the HDL fraction in this study, apoA-V levels may affect some of these metabolic pathways. Enhanced LCAT activity is demonstrated in apoA-V vector-treated apoC-transgenic mice 24) ; however, in order to clarify the precise mechanism in humans, further studies should be encouraged.
In summary, our results obtained from preadolescent children suggest that the apoA-V level is a potent modulator of not only VLDL but also HDL metabolism in the healthy state. Subclass analyses demonstrated the effect of apoA-V on larger HDL particles, providing new insights into the underlying mechanisms. Furthermore, to clarify the contribution of apoA-V to the development of metabolic syndrome or premature atherosclerosis in children with hypertriglyceridemia and/or reduced HDL-C levels, further studies should be conducted in future.
